Watch Pulmonary Hypertension Summit on-demand webcast series, recorded from the 2025 Pulmonary Hypertension Summit. The focus of the education is to provide you with an overview of the practical issues in the diagnosis, evaluation, and management of patients with pulmonary hypertension. Expert speakers present the most recent advances in the context of challenges faced by physicians and other health care providers caring for these patients. Additionally, the education addresses advances in diagnosis and risk stratification, emerging therapeutics, management of populations with concomitant disease, and technological innovations.
Webcasts
Release date: 3/16/25
Expiration date: 3/15/27
Estimated Time: 3 hours
Type: Webcast
Technical Requirements: None
Specialty: pulmonology, critical care
Release date: 3/16/25
Expiration date: 3/15/27
Estimated Time: 1 hour and 30 minutes
Type: Webcast
Technical Requirements: None
Specialty: pulmonology, critical care
Release date: 3/16/25
Expiration date: 3/15/27
Estimated Time: 2 hours
Type: Webcast
Technical Requirements: None
Specialty: pulmonology, critical care
Release date: 3/16/25
Expiration date: 3/15/27
Estimated Time: 2 hours
Type: Webcast
Technical Requirements: None
Specialty: pulmonology, critical care
Release date: 3/16/25
Expiration date: 3/15/27
Estimated Time: 1 hour and 15 minutes
Type: Webcast
Technical Requirements: None
Specialty: pulmonology, critical care
Series Learning Objectives
- Demonstrate optimal procedures for right heart catheterization, echocardiography, and cardiopulmonary exercise tests.
- Detail the evidence base and clinical use of risk assessment tools and treatment algorithms for diagnosing, classifying, and treating pulmonary arterial hypertension.
- Critically review the pharmacologic profile, efficacy and side effect data, and clinical indications for sotatercept and discuss its role in treating pulmonary arterial hypertension.
- Summarize research advances in the pathobiology, diagnosis, and treatment of pulmonary hypertension as well as clinical trial design.
- Describe the diagnosis and management of concomitant conditions that occur in patients with pulmonary hypertension, including chronic lung disease, heart failure, right ventricular dysfunction, connective tissue disease, and thromboembolic pulmonary hypertension.
Target Audience
The online series is directed to physicians, physician assistants, nurse practitioners, nurses, and pharmacists with an interest in pulmonary hypertension.
Acknowledgment
The Cleveland Clinic Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Bayer HealthCare Pharmaceuticals Inc.
ST Shared Services LLC, a Mallinckrodt company
Actelion Pharmaceuticals US, Inc.
United Therapeutics Corporation
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and Cleveland Clinic’s Hospital Based Care Institute.